1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

Pulmonary Drug Delivery Systems Market: Products - Metered Dose Inhalers, Dry Powder Inhalers

MarketResearchReports.Biz presents this most up-to-date research on "Pulmonary Drug Delivery Systems Market: Products - Metered Dose Inhalers, Dry Powder Inhalers"

 
 
MarketResearchReports.Biz
MarketResearchReports.Biz
PRLog - Mar. 4, 2014 - ALBANY, N.Y. -- Pulmonary Drug Delivery Systems Market (Products - Metered Dose Inhalers, Dry Powder Inhalers And Nebulizers; Applications - Asthma, COPD And Cystic Fibrosis) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

This report studies the current scenario as well as the future market potential for pulmonary drug delivery systems, globally. The market for pulmonary drug delivery systems has been segmented into three major product types, namely, metered dose inhalers (MDIs), dry powder inhalers (DPIs) and nebulizers. The market for these systems has been extensively analyzed on the basis of factors such as therapeutic application, geographic presence and technological developments. On the basis of therapeutic application, the market has been segmented into asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2013 to 2019.

Browse complete report with TOC:
http://www.marketresearchreports.biz/analysis-details/pul...

Geographically, the market for pulmonary drug delivery systems has been segmented into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each region has been provided for the period 2011 to 2019 along with the CAGR (%) for the forecast period 2013 to 2019. The study also includes qualitative analysis of the competitive scenario in these regions. The market overview section of the report comprises qualitative analysis of the overall market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis.

The report also provides a section on the competitive landscape of the market, wherein the market share analysis of leading players in the global pulmonary drug delivery systems market, in terms of percentage share in 2012 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and accentuate market shares. The report concludes with the profiles of major players in the global pulmonary drug delivery systems market such as AstraZeneca plc, CareFusion Corporation, GlaxoSmithKline plc, Boehringer Ingelheim, Merck & Co., 3M Health Care, Novartis AG, Omron Healthcare, Inc., PARI Respiratory Equipment, Inc., Sunovion Pharmaceuticals Inc., Philips Respironics, Inc., Allied Healthcare Products, Inc., and GF Health Products Inc.

To Download Sample Report Visit:
http://www.marketresearchreports.biz/sample/sample/164141

The global pulmonary drug delivery systems market is segmented as follows:

Pulmonary Drug Delivery Systems Market, by Product Type
•    Metered Dose Inhalers (MDIs)
•    Dry Powder Inhalers (DPIs)
•    Nebulizers

Pulmonary Drug Delivery Systems Market, by Application
•    Asthma
•    Chronic Obstructive Pulmonary Disease (COPD)
•    Cystic Fibrosis

Pulmonary Drug Delivery Systems Market, by Geography
•    North America
•    Europe
•    Asia-Pacific
•    Rest of the World (RoW)

To buy this Report:
http://www.marketresearchreports.biz/analysis/164141

Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Increasing patient base affected with respiratory diseases
3.2.2 Advantages associated with pulmonary drug delivery route
3.2.3 Technical advances in pulmonary drug delivery systems as well as drug formulations
3.2.4 Expanding therapeutic applications
3.3 Market Restraints

Contact US:
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
Tel: +1-518-618-1030
E-mail: sales@marketresearchreports.biz


--- End ---

Click to Share

Contact Email:
***@marketresearchreports.biz
Source:MarketResearchReports.Biz
City/Town:Albany - New York - United States
Industry:Marketing, Medical
Tags:Pulmonary Drug, Dry Powder Inhalers, Nebulizers; Applications
Shortcut:prlog.org/12290374
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share